Pharmacological characterization of the bradykinin B2 receptor: Inter-species variability and dissociation between binding and functional responses

British Journal of Pharmacology

Volumn 126, Issue 5, 1999, Pages 1083-1090

  Paquet, J L ^a   Luccarini, J M ^a   Fouchet, C ^a   Defrene E ^a   Loillier, B ^a   Robert, C ^a   Belichard P ^a   Cremers, B ^a   Pruneau, D ^a  

^a Laboratoires Fournier SA   (France)

Author keywords

Bradykinin; Hoe 140 (icatibant); Kinin B2 receptors; Non peptide antagonists

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B2 RECEPTOR; BUFFER; DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 7 DEXTRO PHENYLALANINE]; ICATIBANT; INOSITOL TRISPHOSPHATE; TRITIUM; [[4 [2 [[BIS(CYCLOHEXYLAMINO)METHYLENE]AMINO] 3 (2 NAPHTHYL)PROPIONAMIDO]PHENYL]METHYL]TRIBUTYLPHOSPHONIUM CHLORIDE;

ANIMAL CELL; ARTICLE; CHO CELL; HUMAN; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SPECIES DIFFERENCE; UMBILICAL VEIN; UTERUS;

EID: 0032975843     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702403     Document Type: Article

References (31)

1. ARAMORI, I., ZENKOH, J., MORIKAWA, N., O'DONNELL, N., ASANO, M., NAKAMURA, K., IWAMI, M., KOJO, H. & NOTSU, Y. (1997). Novel subtype-selective non-peptide bradykinin antagonists FR167344 and FR173657. Mol. Pharmacol., 51, 171-176.
2. 2 receptor antagonist, FR173657. Br. J. Pharmacol., 120, 617-624.
3. 2 receptor. J. Pharmacol. Exp. Ther., 275, 1623-1630.
4. BATHON, J.M., MANNING, D.C., GOLDMAN, D.W., TOWNS, M.C. & PROUD, D. (1992). Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J. Pharmacol. Exp. Ther., 260, 384-392.
5. BERRIDGE, M.J., DAWSON, R.M.C., DOWNES, C.P., HESLOP, J.P. & IRVINE, R.F. (1982). Lithium amplifies agonist-dependent phosphatidyl inositol responses in brain and salivary gland. Biochem. J., 206, 587-595.
6. BHOOLA, K.D., FIGUEROA, C.D. & WORTHY, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev., 44, 1-79.
7. BRADFORD, M.M. (1976). A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 721, 248-254.
8. BURCH, R.M., KYLE, D.J. & STORMANN, T.M. (1993). Structural insight into bradykinin receptor via conformationally constrained peptides. In Molecular biology and pharmacology of bradykinin receptors. Eds. Burch, R.M., Kyle, D.J. & Stormann, T.M. pp. 93-104. Austin: RG Landes Company.
9. CHEN, C. & OKAYAMA, H. (1987). High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7, 2745-2752.
10. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
11. 2-receptor agonist, U46619. Br. J. Pharmacol., 110, 360-368.
12. 2 receptor gene. Biochem. Biophys. Res. Commun., 187, 1306-1313.
13. FALCONE, R.C., HUBBS, S.J., VANDERLOO, J.D., PROSSER, J.C., LITTLE, J., GOMES, B., AHARONY, D. & KRELL, R.D. (1993). Characterization of bradykinin receptors in guinea pig gall bladder. J. Pharmacol. Exp. Ther., 266, 1291-1299,.
14. 2 receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther., 273, 1071-1077.
15. 2 type characterized by radioligand binding. Br. J. Pharmacol., 122, 1450-1454.
16. 9-bradykinin. J. Biol. Chem., 259, 9623-9268.
17. 2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release in vitro and in vivo. Br. J. Pharmacol., 121, 469-476.
18. HALL, J.M. (1992). Bradykinin receptors: pharmacological properties and biological roles. Pharmac. Ther., 56, 131-190.
19. 2 bradykinin receptors. Mol. Pharmacol., 45, 1-8.
20. HESS, J.F., BORKOWSKI, J.A., YOUNG, G.S., STRADER, C.D. & RANSOM, R.W. (1992). Cloning and pharmacological characterization of a human bradykinin BK2 receptor gene. Biochem. Biophys. Res. Commun., 184, 260-268.
21. KENAKIN, T. (1993). Allotopic, noncompetitive, and irreversible antagonism. In Pharmacologic Analysis of Drug-Receptor Interaction. Ed. Kenakin, T. pp. 323-343. New York: Raven Press.
22. s-mediated stimulation of the cyclic AMP pathway. Biochem. J., 313, 109-118.
23. 2 receptors on the venoconstrictor action of bradykinin. J. Pharmacol. Exp. Ther., 269, 1136-1143.
24. 2 bradykinin receptor. Proc. Natl. Acad. Sci. U.S.A., 88, 7724-7728.
25. PHAGOO, S.B., YAQOOB, M., BROWN, M.C.S. & BURGESS, G.M. (1996). Selective labelling of bradykinin receptor subtypes in WI38 human lung fibroblasts. Br. J. Pharmacol., 119, 863-868.
26. 2 receptor. J. Biol. Chem., 273, 1309-1315.
27. RANSOM, R.W., GOODMAN, C.B. & YOUNG, G.S. (1992). Bradykinin stimulation of phosphoinositoside hydrolysis in guinea-pig ileum longitudinal muscle. Br. J. Pharmacol., 105, 919-924.
28. 2 receptor antagonist. An in vitro study. Hypertension, 29, 951-956.
29. 2 receptor antagonist. Proc. Natl. Acad. Sci. U.S.A., 91, 4693-4697.
30. STEWART, J.M. (1995). Bradykinin antagonists: development and applications. Biopolymers, 37, 143-155.
31. TALLARIDA, R.J. & MURRAY, R.B. (1981). Manual of Pharmacologic Calculations with Computer Programs. New York: Springer-Verlag.